Goldman Sachs Group Inc Kempharm, Inc Transaction History

Goldman Sachs Group Inc

$780 Billion
Q3 2025

A detailed history of Goldman Sachs Group Inc transactions in Kempharm, Inc stock. As of the latest transaction made, Goldman Sachs Group Inc holds 761,777 shares of KMPH stock, worth $3.76 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

761,777

Previous 374,792 103.25%

Holding current value

$3.76 Million

Previous $1.85 Million 103.3%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	N/A	386,985 Added 103.25%	761,777 $3.76 Million
Q2 2025 Aug 14, 2025	BUY	N/A	179,979 Added 92.39%	374,792 $1.85 Million
Q1 2025 May 09, 2025	SELL	N/A	-55,122 Reduced 22.05%	194,813 $962,000
Q4 2024 Feb 11, 2025	BUY	N/A	124,100 Added 98.62%	249,935 $1.23 Million
Q3 2024 Nov 14, 2024	BUY	N/A	91,355 Added 264.95%	125,835 $621,000

Q2 2024 Aug 13, 2024	BUY	N/A	14,455 Added 72.18%	34,480 $170,000
Q1 2024 May 15, 2024	SELL	N/A	-15,678 Reduced 43.91%	20,025 $98,000
Q4 2023 Feb 13, 2024	BUY	N/A	5,337 Added 17.58%	35,703 $176,000
Q3 2023 May 14, 2024	SELL	N/A	-5,337 Reduced 14.95%	30,366 $150,000
Q3 2023 Nov 14, 2023	SELL	N/A	-6,257 Reduced 17.08%	30,366 $150,000
Q2 2023 May 14, 2024	BUY	$4.94 - $6.29 $18,732 - $23,851	3,792 Added 11.55%	36,623 $180,000
Q2 2023 Aug 14, 2023	BUY	$4.94 - $6.29 $18,732 - $23,851	3,792 Added 11.55%	36,623 $180,000
Q1 2023 May 14, 2024	BUY	$4.13 - $6.27 $39,263 - $59,608	9,507 Added 40.76%	32,831 $180,000
Q1 2023 May 11, 2023	BUY	$4.13 - $6.27 $39,263 - $59,608	9,507 Added 40.76%	32,831 $180,000
Q4 2022 May 14, 2024	SELL	$4.12 - $5.62 $12,726 - $17,360	-3,089 Reduced 11.69%	23,324 $107,000
Q4 2022 Feb 13, 2023	SELL	$4.12 - $5.62 $12,726 - $17,360	-3,089 Reduced 11.69%	23,324 $107,000
Q3 2022 May 14, 2024	SELL	$4.5 - $6.85 $228,271 - $347,479	-50,727 Reduced 65.76%	26,413 $165,000
Q3 2022 Nov 10, 2022	SELL	$4.5 - $6.85 $228,271 - $347,479	-50,727 Reduced 65.76%	26,413 $0
Q2 2022 May 14, 2024	BUY	$4.02 - $5.21 $166,576 - $215,886	41,437 Added 116.06%	77,140 $344,000
Q2 2022 Aug 15, 2022	SELL	$4.02 - $5.21 $301,572 - $390,843	-75,018 Reduced 49.3%	77,140 $344,000
Q1 2022 May 16, 2022	SELL	$5.0 - $9.26 $193,160 - $357,732	-38,632 Reduced 20.25%	152,158 $766,000
Q4 2021 Feb 14, 2022	BUY	$7.6 - $10.26 $167,967 - $226,756	22,101 Added 13.1%	190,790 $1.66 Million
Q3 2021 Nov 10, 2021	BUY	$8.72 - $13.31 $1.47 Million - $2.25 Million	168,689 New	168,689 $1.57 Million

Others Institutions Holding KMPH

# of Institutions

178

Shares Held

36.6M

Call Options Held

4.73M

Put Options Held

1.25M

View Full List

About KEMPHARM, INC

Ticker KMPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,493,600
Market Cap $170M
Description
KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds t...

More about KMPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Kempharm, Inc Transaction History